- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | CVRx expects $56M-$57M 2026 revenue amid Medicare Advantage prior authorization delays | 4 | Seeking Alpha | ||
| Fr | CVRx stock downgraded by Canaccord on guidance cut, payer headwinds | 2 | Investing.com | ||
| Fr | CVRx-Aktie von Canaccord nach Prognosesenkung und Gegenwind bei Kostenträgern herabgestuft | 1 | Investing.com Deutsch | ||
| Fr | William Blair downgrades CVRx stock rating on reimbursement headwinds | 2 | Investing.com | ||
| CVRX Aktie jetzt für 0€ handeln | |||||
| Fr | CVRx: William Blair stuft Medizintechnik-Aktie wegen Gegenwind bei Kostenerstattungen herab | 1 | Investing.com Deutsch | ||
| Do | CVRx, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| Do | CVRx, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| Do | CVRx, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.10. | CVRx Reports Q2 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| 29.09. | CVRx, Inc.: CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026 | 3 | GlobeNewswire (USA) | ||
| 23.09. | CVRx Appoints John Landry As CFO To Support Barostim Commercial Expansion | 1 | pulse2.com | ||
| 22.09. | CVRx taps new CFO from Nyxoah | 2 | MassDevice | ||
| 22.09. | Canaccord reiterates CVRx stock Buy rating after CFO appointment | 1 | Investing.com | ||
| 21.09. | CVRx Appoints As John Landry CFO | 5 | RTTNews | ||
| 21.09. | CVRx appoints medical device veteran John Landry as new CFO | 5 | Seeking Alpha | ||
| 21.09. | CVRx appoints John Landry as chief financial officer | 5 | Investing.com | ||
| 21.09. | CVRx, Inc.: CVRx Appoints John Landry as Chief Financial Officer | 259 | GlobeNewswire (Europe) | MINNEAPOLIS, Sept. 21, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation... ► Artikel lesen | |
| 17.09. | CVRx informiert zum Weltherztag am 29. September / Bluthochdruck: Den wichtigsten Risikofaktor für Herz-Kreislauf-Erkrankungen früh erkennen und behandeln | 444 | news aktuell | Minneapolis (ots) - Herz-Kreislauf-Erkrankungen sind die häufigste Todesursache in Deutschland und weltweit. Viele Risikofaktoren wie Bluthochdruck, erhöhte Cholesterinwerte oder Diabetes entwickeln... ► Artikel lesen | |
| 25.08. | CVRx has an activist investor urging it to get acquired | 3 | MassDevice | ||
| 25.08. | CVRx responds to shareholder letter on company valuation | 2 | Investing.com |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,920 | -1,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 0,508 | -12,41 % | Cerenome names Ron Andrews as chief business officer | ||
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | -11,31 % | Tandem Diabetes Care names successor as CEO Sheridan retires | ||
| CO-DIAGNOSTICS | 0,289 | 0,00 % | Co-Diagnostics Reports Third Quarter 2026 Financial Results | Two Regulatory Submissions Under Review in India and the U.S. Third Quarter Operating Expenses Down 12% Year Over YearPlatform Capabilities Expanding with ReadyGo Collaboration, India Connectivity and... ► Artikel lesen | |
| QUIDELORTHO | 10,730 | +3,82 % | QuidelOrtho expects over $80M in 2027 annual savings as it narrows 2026 revenue to $2.52B-$2.54B | ||
| VERU | 2,140 | +0,94 % | Veru executive to present obesity drug data at industry conference | ||
| LIFEWARD | 5,840 | +0,52 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,290 | -2,50 % | Clover Health auf der UBS Global Healthcare Conference: Starkes Wachstum trifft auf steigende Ertragskraft | ||
| SENSEONICS | 9,200 | +2,22 % | Senseonics delivers 'breakout quarter' more than doubling Eversense 365 revenue | ||
| TEMPEST THERAPEUTICS | 0,373 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| NANO-X IMAGING | 0,378 | +1,18 % | Nanox.AI signs distribution deal for cardiac imaging in Thailand | ||
| IMUNON | 0,780 | +13,04 % | IMUNON präsentiert translationale Daten aus Phase-2-Studie bei Eierstockkrebs |
CVRX INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,696 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CVRX INC finden Sie auf Wallstreet Online.